Johnson & Johnson (NYSE:JNJ) on 10/18/2018 declared a dividend of $ 0.9000 per share payable on December 11, 2018 to shareholders of record as of November 27, 2018.

Johnson & Johnson (NYSE:JNJ) has paid dividends since 1944, has a current dividend yield of 2.58% and has increased its dividends for 55 successive years.

Johnson & Johnson's market cap is $ 374,137,151,760 and has a PE ratio of 268.19. The stock price closed yesterday at $ 139.46 and has a 52 week low/high of $ 118.62 and $ 148.32.

Johnson & Johnson is a holding company engaged in the research and development, manufacture and sale of a range of products in the health care field. Co. is organized into three business segments: Consumer, which includes a range of products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health and wound care markets; Pharmaceutical, which is focused on six therapeutic areas: immunology, infectious diseases and vaccines, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension; and Medical Devices, which includes products used in the orthopaedic, surgery, cardiovascular, diabetes care and eye health fields.

For more information on Johnson & Johnson click here.